Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: The cardiovascular and renal effects of glucagon-like peptide 1 receptor agonists in patients with advanced diabetic kidney disease

Fig. 2

Cumulative Event Rate of Primary CV outcomes, Progression to Dialysis, All-cause Mortality, and MALEs. GLP-1RAs had a neutral effect on composite CV outcomes, but delayed progression to dialysis, and reduced all-cause mortality and MALEs compared with DDP-4is. CV cardiovascular; GLP-1RA glucagon-like peptide 1 receptor agonist; DPP-4i dipeptidyl peptidase 4 inhibitor; MALEs major adverse limb events

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840